Skip Navigation

Research Meeting Summaries

Filter Research Meeting Summaries

September 5, 2012 to September 6, 2012

In September 2012, experts from the National Institutes of Health (NIH), Department of Defense (DoD), U.S. Food and Drug Administration (FDA), Department of Veterans Affairs (VA), academia, and industry attended a workshop to discuss new findings on the risks and benefits of FDA-approved HES, which is used to treat low blood volume.

June 21, 2012

In June 2012, a working group recommended actions to advance the development and application of point-of-care (POC) technologies as tools for diagnosis and monitoring in clinical cardiovascular research.

June 14, 2012 to June 15, 2012

In June 2012, a working group explored the issues relevant to thrombosis (prevention, detection/surveillance, and treatment) in pediatric cardiology and adult congenital heart disease patients and made recommendations to improve the knowledge base in this field.

June 5, 2012

In June 2012, a working group discussed current knowledge and future directions for research in prediction, prevention, and treatment of pulseless electrical activity (PEA), which is a clinical condition characterized by unresponsiveness and lack of a pulse despite organized cardiac electrical activity.

December 14, 2011 to December 15, 2011

This report summarizes a December 2011 workshop at which experts recommended steps to advance research on the role of the lung microbiome in asthma, COPD, and cystic fibrosis.

September 13, 2011 to September 14, 2011

This report summarizes a September 2011 workshop at which experts discussed the opportunities for and obstacles to the development of cellular therapies for pediatric patients.

September 6, 2011 to September 7, 2011

This report summarizes a September 2011 workshop at which experts identified key knowledge gaps and priority areas in lung development research.

September 6, 2011 to September 7, 2011

This report summarizes a September 2011 State of the Science Symposium on the Myelodysplastic Syndromes (MDS), which are a group of bone marrow stem cell disorders involving ineffective blood cell formation.

Page 8 of 15

Pages